RIZATRIPTAN AH rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Pieejams no:

Arrotex Pharmaceuticals Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

rizatriptan benzoate

Zāļu forma:

Tablet, orally disintegrating

Kompozīcija:

Excipient Ingredients: crospovidone; silicon dioxide; sodium stearylfumarate; mannitol; acesulfame potassium; colloidal anhydrous silica; ethylcellulose; hypromellose; Flavour

Ievadīšanas:

Sublingual

Vienības iepakojumā:

6, 3, 2

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

for acute treatment of migraine attacks with or without aura.

Produktu pārskats:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorizācija statuss:

Licence status A

Autorizācija datums:

2015-03-20